QWM
WST icon

Quaker Wealth Management’s West Pharmaceutical WST Stock Holding History

Quaker Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$224 – 1739
2025
Q1 		$224 Buy
+1
New +$276 ﹤0.01% 835

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Quaker Wealth Management's WST Position: Q2 2026 in Review

Quaker Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 1 share worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Quaker Wealth Management first reported a position in WST in Q2 2025 and has held it in 5 quarters since. The position peaked at $551 in Q4 2025. 240 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Quaker Wealth Management held 1 share of West Pharmaceutical worth $359 as of Q2 2026.
  • Quaker Wealth Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #808 holding.
  • Quaker Wealth Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's West Pharmaceutical position peaked at $551 in Q4 2025.
  • 240 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.